KP
Kalpit Patel B. Riley Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
17
Avg Return
Past Year
Past Year
18%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
53.8%
Neutral
46.2%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $117 |
37%
upside
| 3 | +46% |
0
%
| 22 Dec ‘25 5 months ago |
|
|
|
Buy
Maintained
| $3 |
194%
upside
| 1 | -15% |
0
%
| 25 Nov ‘25 6 months ago |
|
|
|
Peer Perform
Initiated
| – | – | 1 | – |
–
| 18 Nov ‘25 6 months ago |
|
|
|
Peer Perform
Initiated
| – | – | 1 | – |
–
| 18 Nov ‘25 6 months ago |
|
|
|
Peer Perform
Initiated
| – | – | 1 | – |
–
| 18 Nov ‘25 6 months ago |
|
|
|
Peer Perform
Initiated
| – | – | 1 | – |
–
| 18 Nov ‘25 6 months ago |
|
|
|
Peer Perform
Initiated
| – | – | 1 | – |
–
| 18 Nov ‘25 6 months ago |
|
|
|
Peer Perform
Initiated
| – | – | 1 | – |
–
| 18 Nov ‘25 6 months ago |
|
|
|
Outperform
Initiated
| $42 |
9%
downside
| 1 | +12% |
0
%
| 18 Nov ‘25 6 months ago |
|
|
|
Outperform
Initiated
| $75 | – | 1 | -27% |
0
%
| 18 Nov ‘25 6 months ago |
|
|
|
Outperform
Initiated
| $75 |
53%
downside
| 1 | +43% |
0
%
| 18 Nov ‘25 6 months ago |
|
|
|
Outperform
Initiated
| $110 |
25%
upside
| 1 | +27% |
0
%
| 18 Nov ‘25 6 months ago |
|
|
|
Buy
Maintained
| $12 |
89%
upside
| 1 | +1.4% |
0
%
| 30 Jul ‘25 10 months ago |
|